1. |
|
2. |
Srivastava M,Lippes J,Fichorova R,et al.Soluble Fas(sFas)and Soluble Fas ligand(sFasL)in human reproductive tract fluid[M].IN:Processings of the 45th Annual Meeting of the Society for Gynecologic Investigation;Chicago,IL.Abstract T203..
|
3. |
de los Santos MJ,Anderson DJ,Racowsky C et al.Presence of FasFas ligand system and Bcl2 gene products in cells and fluids from gonadotropinstimulated human ovaries[J].Biol Reprod,2000,63:1811-1816..
|
4. |
马黔红,李尚为,黄仲英,等.长效促性腺激素释放激素激动剂用于体外受精胚胎移植中降调节后延迟卵巢启动时间的探讨[J].实用妇产科杂志,2006,22:603-606..
|
5. |
Kayagaki N,Kawasaki A,Ebata T,et al.Metalloproteinasemediated release of human Fas ligand[J].J Exp Med,1995,192:1777-1783..
|
6. |
Cataldo NA,Fujimoto VY,Jaffe RB.Interferongamma and activin A promote insulinlike growth factorbinding protein2 and 4 accumulation by human luteinizing granulosa cells,and interferongamma promotes their apoptosis[J].J Clin Endocrinol Metab,1998,83:179-186..
|
7. |
Quirk SM,Cowan RG,Joshi SG,Henrikson KP.Fas antigenmediated apoptosis in human granulosa/luteal cells[J].Biol Reprod,1995,52:279-287..
|
8. |
Porter DA,Harman RM,Cowan RG,et al.Susceptibility of ovarian granulosa cells to apoptosis differs in cells isolated before or after the preovulatory LH surge[J].Mol Cell Endocrinol,2001,15:13-20..
|
9. |
Westergaard LG,Erb K,Laursen SB,et al.Concentrations of gonadotropins and steroids in preovulatory follicular fluid and serum in relation to stimulation protocol and outcome of assisted reproduction treatment[J].RBMonline,2004,8:516-523..
|
10. |
Slot KA,de BoerBrouwer M,Houweling M et al.Luteinizing hormone inhibits Fasinduced apoptosis in ovarian surface epithelial cell lines[J].J Endocrinol,2006,188:227-239.
|
11. |
Chen Q,Yano T,Matsumi H,et al.Crosstalk between Fas/Fas ligand system and nitric oxide in the pathway subserving granulosa cell apoptosis:a possible regulatory mechanism for ovarian atresia[J].Endocrinology,2005,146:808-815.
|